ArticlePLoS pathogens2023

The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas.

Tesia L Cleverley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.